HK-listed SciClone Pharma jumps on inclusion in Shenzhen-HK stock connect program

SciClone Pharmaceuticals (Holdings)

06/09/2021 08:56

** Shares of oncology and severe infection-focused drug
maker SciClone Pharmaceuticals (Holdings) Ltd  6600.HK  jump as
much as 10.5% to HK$11.38, their biggest daily percentage gain
since listing on March 3
    ** Stock hit the highest since Aug. 20, on course for the
second session of gains
    ** Company says it has been included as an eligible stock of
Shenzhen-Hong Kong Stock Connect effective Sept. 6 and expects
the inclusion will help expand its shareholder base and increase
the trading liquidity of the shares  urn:newsml:reuters.com:*:nFWN2Q802T
    ** New joiner Hutchmed (China)  0013.HK  also rises 2.8% to
HK$67.55, the highest since Aug. 11, and on track for fourth
straight session of gains 
    ** Hutchimed says it is included in the Shanghai-Hong Kong
Stock Connect and Shenzhen-Hong Kong Stock Connect programs
effective Sept. 6 (https://bit.ly/2WUNhWo)
    ** Hong Kong's healthcare index  .HSCIH  surges 2.3% and the
Hang Seng Composite Index  .HSCI  rises 1%
    ** The Hang Seng China Enterprises Index  .HSCE  climbs 0.8%
and the benchmark index  .HSI  gains 0.9%


 (Reporting by Donny Kwok, Editing by Louise Heavens)
 ((donny.kwok@thomsonreuters.com))